News

Body image is part physical and part mental. If weight loss alone isn't helping, strategies from body image psychology can ...
Weight-loss drugs like Ozempic and Wegovy are used by more than 15 million adults in the U.S., or 4.5% of the population.
Eli Lilly and Company thrives on its groundbreaking weight-loss drug tirzepatide. Learn why we could see a $50B market and ...
Detailed price information for Novo Nordisk A/S ADR (NVO-N) from The Globe and Mail including charting and trades.
The deal, which could be worth up to $870 million overall, will give Lilly access to a delivery technology that may help ...
That’s up from a rate of 9.9 prescriptions per 100,000 in 2023, the first full year that Wegovy was available to children ...
American teens are increasingly turning to the weight-loss drug Wegovy as more families and their doctors gain confidence in its use ...
American teens are increasingly turning to the weight-loss drug Wegovy as more families and their doctors gain confidence in ...
Novo Nordisk ( NVO, Financials) is seeing more U.S. teens start treatment with its GLP-1 drug Wegovy; new data shows a 50% ...